Commentary
Nature Biotechnology 25, 39 - 43 (2007)
doi:10.1038/nbt0107-39
Animal cloning and the FDA—the risk assessment paradigm under public scrutiny
Larisa Rudenko1, John C Matheson1 & Stephen F Sundlof1
- Larisa Rudenko, John C. Matheson and Stephen F. Sundlof are at the Center for Veterinary Medicine, US Food and Drug Administration, Department of Health and Human Services, 7500 Standish Place, Rockville, Maryland 20855, USA. e-mail: larisa.rudenko@fda.hhs.gov
Abstract
The evidence gathered thus far—ultimately to be published in the Draft Risk Assessment on Animal Cloning—indicates that there are no unique risks associated with animal cloning.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
